Founding Infinimmune Infinimmune & Developing Breakthrough Tools for Antibody Discovery with Wyatt McDonnell Wyatt McDonnell axial100.substack.com/p/founding-inf…

Our team at Pear VC is incredibly excited about the future of biotech! With recent breakthroughs in personalized medicine, gene editing, AI/ML, and more, the opportunities to drastically improve human health are limitless. We have our Partner Eddie leading pear.vc/people/eddie-e…

Our #TechBio #Founder #Series #Podcast #14 is out ! Tune in to learn more on how to use our knowledge of the #immune #system to turn human bodies into #drugs #factories with Wyatt McDonnell, CEO Infinimmune: shorturl.at/demr0

Thanks to Next Sequence Ventures and Loretta TIOIELA 🇺🇦 for featuring our story!

Bringing first-in-class targets to market first beats a best-in-class therapeutic modality, per Boston Consulting Group’s recent analysis of the last decade of biopharma product launches. We don’t need more fast followers. We need new target biology. nature.com/articles/d4157…

Founder Spotlight 🔬: Wyatt McDonnell Infinimmune Learn about Wyatt McDonnell and his formative experiences at 10x Genomics, building antibodies Infinimmune that "nature has already validated," having multiple co-founders, and much more below... ow.ly/T3Lj50NR2CY

Founder Spotlight 🔬: Wyatt McDonnell Infinimmune Learn about Wyatt McDonnell and his formative experiences at 10x Genomics, building antibodies Infinimmune that "nature has already validated," having multiple co-founders, and much more below... ow.ly/T3Lj50NR2CY

Our annual Biotech Forum is Wednesday, May 24, featuring a one-on-one interview on-stage with new Vir Biotechnology CEO Marianne De Backer, MSc, PhD, MBA and three presentations from up-and-coming companies Siolta Therapeutics Infinimmune and HOPO Therapeutics bizjournals.com/sanfrancisco/e…

This past December, Pear VC was proud to invest in Infinimmune's $12M seed round. In this blog, I reflect on the broader field of antibody-based therapeutics and why we are excited about Infinimmune's team, technical approach, and vision. Check it out!👇 pear.vc/investing-in-i…

Thanks Eddie Eltoukhy for the feature and to Mar Hershenson, Pejman Nozad, and the rest of the Pear team for your support!

We're happy to stand alongside our friend + trailblazing investor Eddie Eltoukhy from Pear VC and our friends Playground Global in supporting the amazing innovation behind Infinimmune! Awesome founding team + CEO Wyatt McDonnell. No one explains complex science better than

It's been a busy week -- events in RTP, Boston, SF, Toronto, and Belgium! But if you're not in one of those cities, don't worry -- we have our next online Q&A on Tuesday, June 27th at 12pm PT with Wyatt McDonnell of Infinimmune! Come with questions about single-cell & Abs!

Really solid and interesting interview from Wyatt McDonnell and Axial. Love hearing about computational immunology!! axial.substack.com/p/founding-inf…

We're looking for a computational biologist to join our team as we build better drugs for humans, from humans! Must love: dumplings (you'll see what we mean when you're onsite), GitHub, NGS data, Rust/Python/R, and inventing new technology as part of a team.

Rockstar computational biologists - please apply! linkedin.com/jobs/view/3670…

Sharing the opportunity below for any computational biologists in my network - excellent team, fascinating science, and huge potential positive impact on patients!

Our team is excited to collaborate with Grid Therapeutics to discover novel antibody therapeutics from cancer survivors with exceptional outcomes. businesswire.com/news/home/2023…

A good group of people at Infinimmune, I managed to get to know some of them personally. Looking forward to their exciting developments. #biotech #AntibodyDiscovery #AntibodyDx #AntibodyTx genomeweb.com/sequencing/inf…

Timely discussion on "Removing Barriers: Creating #healthcare access & equity by panel EBD Group Demy Colton at #BiotechShowcase in SF, Jan 2024 @IpsenUS Syneos Health Wyatt McDonnell Infinimmune - Health Equity Coalition for Chronic Disease Health Equity SF Health Access CA HealthEquity Women In Bio

$86 million healthcare conference #JPMorgan2024 is back in SF. Can it keep the "safe, secure, clean" momentum going? sfchronicle.com/sf/article/s-f… Talked to CEOs Sabrina Martucci Johnson Daré Bioscience, Inc. brent vaughan @Cognitotx Jake Becraft Strand Therapeutics Wyatt McDonnell Infinimmune Marc Jones Altoida, Inc.